INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 45h ago
HOUSE PTR5h ago
SEC 13F5h ago
ROBINHOOD CHAIN5h ago
SEC FORM 4/Grant or awardVerified data

Simantov Ronit reported TPST

Director · Tempest Therapeutics, Inc. · Tempest Therapeutics, Inc. — Stock Option (right to buy)

Side
A
Value
—
Shares
1,230
Price
—
Executed
Jan 27, 2026
Disclosed
Jan 28, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Jan 27 executedJan 28, 2026 disclosed

TPST · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
9/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+1 / 25

No reported dollar value · new position

  • Filing timing0 / 15

    Disclosed 1 business day after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · TPST

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    47
    AM
    Angel MatthewDirector, CEO and President, 10% Owner
    TPSTTempest Therapeutics, Inc.
    Open-market purchase
    		BUY$500K
    231.5K sh
    		Mar 24, 2026Mar 25, 2026
    traded Mar 24, 2026
    		+1dSEC FORM 4

    Evidence

    9
    AM
    Angel MatthewDirector, CEO and President, 10% Owner
    TPSTTempest Therapeutics, Inc.
    Grant or award
    		A—
    269.6K sh
    		Feb 4, 2026Feb 6, 2026
    traded Feb 4, 2026
    		+2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001871563-26-000002
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Jan 27, 2026
    Published
    Jan 28, 2026
    Ingested by INSIDER
    Nov 5, 04:20 UTC
    Last re-read
    Nov 5, 04:20 UTC

    Extracted facts

    Filer
    Simantov Ronit
    Role
    Director
    Transaction
    Grant or awardAs filed: “A”
    Asset
    Tempest Therapeutics, Inc. — Stock Option (right to buy)
    Ticker
    TPST
    Shares
    1,230
    Price per share
    $0
    Execution date (reported)
    Jan 27, 2026
    Owned after transaction
    1,230 shares
    Days from execution to publication
    1

    What this establishes

    Simantov Ronit filed this Form 4 reporting a grant or award of TPST on Jan 27, 2026. It became public on Jan 28, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director
    Simantov Ronitcik:0001871563
    Issuer
    Tempest Therapeutics, Inc.cik:0001544227

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.